fluorouracil has been researched along with 10-hydroxycamptothecin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 10 (71.43) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ding, J; Gao, H; Huang, M; Li, C; Lu, W; Shen, H; Sun, J; Zhang, X | 1 |
| Tang, HF; Yi, YH; Zhang, SY | 1 |
| Shen, ZM; Wang, XW; Xu, B; Yang, JL; Yu, WJ | 1 |
| Li, N; Ou, Q; Shen, B; Wang, H; Yu, B; Zhang, H; Zheng, M | 1 |
| Agrawal, S; Nan, L; Wang, H; Yu, D; Zhang, R | 1 |
| Agrawal, S; Lindsey, JR; Nan, L; Wang, H; Yu, D; Zhang, R | 1 |
| Chen, ZH; Feng, B | 1 |
| Ji, J; Ji, YB; Lin, YZ; Liu, BY; Yuan, F; Zhang, J; Zhu, ZG | 1 |
| Cai, W; Chen, JP; Li, XY; Wu, XY; Yao, DF; Yu, JW; Yu, ZJ; Yuan, HX; Yuan, Y | 1 |
| Feng, LF; Lei, XY; Liao, DF; Tang, SS; Zhong, M; Zhu, BY | 1 |
| Cai, X; Guo, YW; Lin, F; Sun, YJ; Tang, LN; Tang, XC; Yao, Y; Zhang, W; Zhao, H | 1 |
| Chen, P; Lin, F; Sun, Y; Tang, L; Yao, Y; Zhao, H | 1 |
| Chen, SZ; Shang, BY; Shang, Y; Zhen, YS | 1 |
| Ding, D; Gao, F; Han, D; Jin, C; Li, J; Li, Y; Lv, C; Sun, Y; Tan, W; Wang, R; Xie, S; Yang, C | 1 |
1 trial(s) available for fluorouracil and 10-hydroxycamptothecin
| Article | Year |
|---|---|
Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Hepatic Artery; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Treatment Outcome | 2005 |
13 other study(ies) available for fluorouracil and 10-hydroxycamptothecin
| Article | Year |
|---|---|
Synthesis and antitumor activity of 7-ethyl-9-alkyl derivatives of camptothecin.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Humans | 2005 |
Bioactive triterpene glycosides from the sea cucumber Holothuria fuscocinerea.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Glycosides; Humans; Molecular Structure; Sea Cucumbers; Triterpenes | 2006 |
[Cytotoxicity of hydroxycamptothecin and four other antineoplastic agents on KB cells].
Topics: Alkaloids; Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Camptothecin; Colony-Forming Units Assay; Fluorouracil; Harringtonines; Homoharringtonine; Humans; Indolizines; KB Cells; Vincristine | 1987 |
The influence of the p53 gene on the in vitro chemosensitivity of colorectal cancer cells.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Camptothecin; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Fluorouracil; Genes, p53; Humans; Male; Middle Aged; Mutation; Retrospective Studies | 1999 |
Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Camptothecin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA, Antisense; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Humans; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2001 |
Anti-tumor efficacy of a novel antisense anti-MDM2 mixed-backbone oligonucleotide in human colon cancer models: p53-dependent and p53-independent mechanisms.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Camptothecin; Colorectal Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Nuclear Proteins; Oligonucleotides, Antisense; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Survival Rate; Treatment Outcome; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
[Effect of the change of caspase-3 activity on the neoadjuvant chemotherapy-induced apoptosis of large-intestinal carcinoma cells].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Caspase 3; Caspases; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged | 2003 |
[Antitumor effects of chemotherapeutic drugs on fresh human gastric cancer cells and their relationships to expressions of P-glycoprotein and glutathione S transferase-pi].
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cell Nucleus; Cisplatin; Cytoplasm; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorouracil; Glutathione S-Transferase pi; Humans; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Tumor Cells, Cultured | 2005 |
Bcl-2 siRNA induced apoptosis and increased sensitivity to 5-fluorouracil and HCPT in HepG2 cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Camptothecin; Caspase 3; Caspases; Cell Line, Tumor; Drug Delivery Systems; Drug Synergism; Flow Cytometry; Fluorouracil; Genes, bcl-2; Humans; Liver Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Tetrazolium Salts; Thiazoles | 2006 |
Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Survival Rate; Treatment Outcome | 2006 |
Combined chemotherapy of hydroxycampothecin with oxaliplatin as an adjuvant treatment for human colorectal cancer.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Line, Tumor; Colorectal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Mice; Middle Aged; Neoplasm Transplantation; Organoplatinum Compounds; Oxaliplatin | 2008 |
[Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
Topics: Aminoglycosides; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Synergism; Enediynes; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluorouracil; HT29 Cells; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Xenograft Model Antitumor Assays | 2011 |
Construction of Bispecific Aptamer-Drug Conjugate by a Hybrid Chemical and Biological Approach.
Topics: Aminobenzoates; Aptamers, Nucleotide; Camptothecin; Cell Line, Tumor; Fluorouracil; Humans; Oligopeptides; Pharmaceutical Preparations | 2020 |